Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

333
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
333
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

862
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
862
Tissue Transplantation01:24

Tissue Transplantation

888
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
888

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of cardiopulmonary exercise testing parameters in young heart failure patients with moderately reduced exercise capacity.

JHLT open·2026
Same author

Waitlist mortality in children with EXCOR support: An analysis of the Japan Excor registry.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Phenotypic spectrum of cardiac conduction disturbance and cardiomyopathy linked to titin canonical splice-site variants.

Cardiovascular research·2025
Same author

Survey on Japanese emergency physicians' awareness of advanced mechanical circulatory support upgrade therapy for patients with out-of-hospital cardiac arrest receiving extracorporeal cardiopulmonary resuscitation.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2025
Same author

Atf3 controls transitioning in female mitochondrial cardiomyopathy as identified by spatial and single-cell transcriptomics.

Science advances·2025
Same author

Heart transplantation with super-aged donors older than 65 years.

JHLT open·2025

Related Experiment Video

Updated: Jan 14, 2026

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
07:08

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

576

Challenges to overcome obstacles for pediatric donor heart availability.

Norihide Fukushima1

  • 1Senri Kinran University, 5-25-1 Fujishiro-dai, Suita, Osaka, 565-0873, Japan.

JHLT Open
|October 27, 2025
PubMed
Summary

Pediatric heart transplantation is crucial for complex congenital heart disease (CHD). This review examines the persistent challenges limiting the availability of donor hearts for children needing this life-saving procedure.

Keywords:
Donation after circulatory death (DCD)Donor evaluation and managementPediatric heart transplantationXenotransplantation

More Related Videos

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

8.3K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.2K

Related Experiment Videos

Last Updated: Jan 14, 2026

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
07:08

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

576
Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

8.3K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.2K

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Transplantation Medicine

Background:

  • Surgical techniques for congenital heart disease (CHD) have advanced.
  • Pediatric heart transplantation is the primary treatment for severe pediatric heart failure due to complex CHD or cardiomyopathy.
  • Limited donor heart availability poses a significant challenge in pediatric transplantation.

Purpose of the Study:

  • To review the historical and current obstacles to increasing the availability of donor hearts for pediatric heart transplantation.
  • To identify key challenges hindering the pediatric donor pool.

Main Methods:

  • Literature review of past and current research on pediatric donor heart availability.
  • Analysis of factors affecting donor organ procurement and allocation for pediatric recipients.

Main Results:

  • Despite surgical advancements, donor heart scarcity remains a critical issue for children with end-stage heart failure.
  • Several factors contribute to the limited availability of pediatric donor hearts, including organ size matching and ethical considerations.

Conclusions:

  • Overcoming the shortage of pediatric donor hearts requires addressing multifaceted challenges.
  • Innovative strategies and policy changes are needed to improve donor heart availability for pediatric heart transplantation.